The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 21, 2016
Filed:
Jun. 23, 2015
Applicants:
Ipsen Pharma S.a.s., Boulogne-Billancourt, FR;
Oncodesign S.a., Dijon, FR;
Inventors:
Jan Hoflack, Malle, BE;
Petra Blom, Destelbergen, BE;
Assignee:
IPSEN PHARMA S.A.S., Boulogne-Billancourt, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/504 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); C07D 487/18 (2006.01); C07D 498/18 (2006.01); C07D 487/16 (2006.01); C07D 498/16 (2006.01); C07D 498/22 (2006.01); C07D 515/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); C07D 487/16 (2013.01); C07D 487/18 (2013.01); C07D 498/16 (2013.01); C07D 498/18 (2013.01); C07D 498/22 (2013.01); C07D 515/16 (2013.01);
Abstract
The present invention relates to novel macrocylic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of LRRK2 (Leucine-Rich Repeat Kinase 2). Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicine or diagnostic agent, in particular for the treatment and/or diagnosis of diseases characterized by LRRK2 kinase activity such as neurological disorders including Parkinson's disease and Alzheimer's disease.